Masimo [MASI] vs Penumbra [PEN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Masimo wins in 7 metrics, Penumbra wins in 12 metrics, with 0 ties. Penumbra appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMasimoPenumbraBetter
P/E Ratio (TTM)129.1667.11Penumbra
Price-to-Book Ratio7.457.58Masimo
Debt-to-Equity Ratio61.5817.04Penumbra
PEG Ratio0.60-0.39Penumbra
EV/EBITDA53.6954.34Masimo
Profit Margin (TTM)-21.32%11.54%Penumbra
Operating Margin (TTM)17.12%12.03%Masimo
EBITDA Margin (TTM)17.12%12.03%Masimo
Return on Equity-22.37%12.03%Penumbra
Return on Assets (TTM)1.84%6.20%Penumbra
Free Cash Flow (TTM)$145.30M$147.30MPenumbra
1-Year Return5.20%30.18%Penumbra
Price-to-Sales Ratio (TTM)3.617.72Masimo
Enterprise Value$8.26B$9.61BPenumbra
EV/Revenue Ratio3.837.51Masimo
Gross Profit Margin (TTM)62.90%65.99%Penumbra
Revenue per Share (TTM)$40$33Masimo
Earnings per Share (Diluted)$-5.15$3.75Penumbra
Beta (Stock Volatility)1.230.45Penumbra
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Masimo vs Penumbra Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Masimo2.46%4.51%6.03%-14.76%-14.83%-13.36%
Penumbra1.55%1.72%-5.94%1.50%-8.60%5.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Masimo5.20%8.76%-39.76%269.00%412.82%629.52%
Penumbra30.18%39.85%17.32%541.75%513.78%513.78%

News Based Sentiment: Masimo vs Penumbra

Masimo

News based Sentiment: POSITIVE

Masimo made significant strategic moves in September, including the divestiture of Sound United and an expanded partnership with Philips. These actions, coupled with positive clinical data and analyst upgrades, suggest a positive trajectory for the company, despite some mixed signals from insider activity and a recent legal settlement. The focus on core healthcare technologies positions Masimo for future growth.

View Masimo News Sentiment Analysis

Penumbra

News based Sentiment: MIXED

September presented a mixed bag for Penumbra, with strong financial results and positive analyst coverage offset by insider selling and a downgrade. The company's growth prospects remain promising, but the conflicting signals suggest a degree of uncertainty that warrants careful consideration by investors.

View Penumbra News Sentiment Analysis

Performance & Financial Health Analysis: Masimo vs Penumbra

MetricMASIPEN
Market Information
Market Cap i$7.77B$9.95B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i737,950440,090
90 Day Avg. Volume i655,770462,633
Last Close$146.05$253.49
52 Week Range$131.60 - $194.88$187.84 - $310.00
% from 52W High-25.06%-18.23%
All-Time High$305.21 (Nov 15, 2021)$348.67 (Jun 26, 2023)
% from All-Time High-52.15%-27.30%
Growth Metrics
Quarterly Revenue Growth0.08%0.13%
Quarterly Earnings Growth2.21%0.13%
Financial Health
Profit Margin (TTM) i-0.21%0.12%
Operating Margin (TTM) i0.17%0.12%
Return on Equity (TTM) i-0.22%0.12%
Debt to Equity (MRQ) i61.5817.04
Cash & Liquidity
Book Value per Share (MRQ)$19.20$33.20
Cash per Share (MRQ)$2.75$10.89
Operating Cash Flow (TTM) i$176.60M$201.49M
Levered Free Cash Flow (TTM) i$92.86M$97.77M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Masimo vs Penumbra

MetricMASIPEN
Price Ratios
P/E Ratio (TTM) i129.1667.11
Forward P/E i30.8166.57
PEG Ratio i0.60-0.39
Price to Sales (TTM) i3.617.72
Price to Book (MRQ) i7.457.58
Market Capitalization
Market Capitalization i$7.77B$9.95B
Enterprise Value i$8.26B$9.61B
Enterprise Value Metrics
Enterprise to Revenue i3.837.51
Enterprise to EBITDA i53.6954.34
Risk & Other Metrics
Beta i1.230.45
Book Value per Share (MRQ) i$19.20$33.20

Financial Statements Comparison: Masimo vs Penumbra

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MASIPEN
Revenue/Sales i$372.00M$324.14M
Cost of Goods Sold i$138.00M$108.26M
Gross Profit i$234.00M$215.88M
Research & Development i$33.90M$22.08M
Operating Income (EBIT) i$80.70M$40.35M
EBITDA i$90.70M$49.20M
Pre-Tax Income i$68.40M$43.86M
Income Tax i$21.20M$4.64M
Net Income (Profit) i$-170.70M$39.22M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MASIPEN
Cash & Equivalents i$130.80M$376.05M
Total Current Assets i$1.18B$999.71M
Total Current Liabilities i$546.50M$158.63M
Long-Term Debt i$657.70M$205.85M
Total Shareholders Equity i$946.40M$1.21B
Retained Earnings i$1.32B$99.23M
Property, Plant & Equipment i$183.60M$274.92M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MASIPEN
Operating Cash Flow i$62.60M$46.01M
Capital Expenditures i$17.00M$-13.47M
Free Cash Flow i$27.00M$35.50M
Debt Repayment i$-78.80M$-613,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMASIPEN
Shares Short i3.72M1.98M
Short Ratio i6.134.25
Short % of Float i0.10%0.07%
Average Daily Volume (10 Day) i737,950440,090
Average Daily Volume (90 Day) i655,770462,633
Shares Outstanding i53.60M38.49M
Float Shares i46.46M37.78M
% Held by Insiders i0.06%0.04%
% Held by Institutions i1.10%0.93%

Dividend Analysis & Yield Comparison: Masimo vs Penumbra

MetricMASIPEN
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A